SMTL ID : 2c6t.1 (1 other biounit)

Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.61 Å

Oligo State

hetero-1-1-mer

Ligands

1 x DT5: 4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE(Non-covalent)

DT5.1: 16 residues within 4Å: Chain A: I.10, G.11, E.12, G.13, V.18, A.31, V.64, E.81, L.83, H.84, Q.85, D.86, K.89, Q.131, N.132, L.134 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:I.10, A:I.10, A:V.18, A:D.86, A:L.134 Hydrogen bonds: A:L.83, A:L.83, A:D.86, A:K.89 Water bridges: A:E.12

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Richardson, C.M. et al., Triazolo[1,5-A]Pyrimidines as Novel Cdk2 Inhibitors: Protein Structure-Guided Design and Sar. Bioorg.Med.Chem.Lett. (2006)

Release Date

2005-12-07

Peptides

CELL DIVISION PROTEIN KINASE 2: A
CYCLIN A2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

CELL DIVISION PROTEIN KINASE 2

CYCLIN A2

Related Entries With Identical Sequence